The store will not work correctly when cookies are disabled.
7-(phenylsulfonyl)-1,2,3,4-tetrahydrobenzofuro[2,3-c]pyridine
ID: ALA1935589
PubChem CID: 57398803
Max Phase: Preclinical
Molecular Formula: C17H15NO3S
Molecular Weight: 313.38
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=S(=O)(c1ccccc1)c1ccc2c3c(oc2c1)CNCC3
Standard InChI: InChI=1S/C17H15NO3S/c19-22(20,12-4-2-1-3-5-12)13-6-7-14-15-8-9-18-11-17(15)21-16(14)10-13/h1-7,10,18H,8-9,11H2
Standard InChI Key: HKCRMSMUMPAIPI-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 25 0 0 0 0 0 0 0 0999 V2000
-5.6247 0.6947 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-4.8010 0.6947 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-5.2128 1.4082 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-4.0827 1.9305 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.0839 1.1043 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.3702 0.6920 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.3720 2.3425 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6576 1.9340 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6573 1.1043 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8681 0.8481 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.8685 2.1907 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3805 1.5182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5586 1.6042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2185 2.3616 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.7065 3.0341 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5348 2.9491 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.7982 -0.1307 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.5120 -0.5405 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.5130 -1.3634 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.7995 -1.7767 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.0834 -1.3610 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.0859 -0.5394 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11 12 2 0
5 6 1 0
6 9 2 0
8 7 2 0
7 4 1 0
8 9 1 0
11 16 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
5 2 1 0
2 1 2 0
2 17 1 0
4 5 2 0
17 18 2 0
3 2 2 0
18 19 1 0
9 10 1 0
19 20 2 0
10 12 1 0
20 21 1 0
11 8 1 0
21 22 2 0
22 17 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 313.38 | Molecular Weight (Monoisotopic): 313.0773 | AlogP: 2.91 | #Rotatable Bonds: 2 |
Polar Surface Area: 59.31 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 8.29 | CX LogP: 2.61 | CX LogD: 1.67 |
Aromatic Rings: 3 | Heavy Atoms: 22 | QED Weighted: 0.79 | Np Likeness Score: -0.67 |
References
1. Sundar BG, Bailey TR, Dunn DD, Bacon ER, Salvino JM, Morton GC, Aimone LD, Zeqi H, Mathiasen JR, Dicamillo A, Huffman MJ, McKenna BA, Kopec K, Lu LD, Brown R, Qian J, Angeles T, Connors T, Spais C, Holskin B, Galinis D, Duzic E, Schaffhauser H, Rosse GC.. (2012) Novel brain penetrant benzofuropiperidine 5-HT₆ receptor antagonists., 22 (1): [PMID:22153937] [10.1016/j.bmcl.2011.11.050] |